Browse Data and Analysis

As of September 2022, Israel does not have a policy restricting the use of imported genetically engineered (GE) commodities or derivative products. There are no changes in Israel’s policy towards plant, animal biotechnology, and microbial biotechnology compared to 2021.

The implementation of Malaysia’s B20 mandate has been officially postponed until the end of 2022. However, it will be difficult for the Government of Malaysia (GoM) to implement the B20 within the current deadline and Post expects the delays to continue into 2023.

The impact of the COVID-19 on the Israeli hotel, restaurant, and institutional (HRI) sector was nothing short of devastating. According to the Israeli Central Bureau of Statistics, accommodation and foodservice activities declined by forty percent in 2020. The sector started to recover during 2021, and it is expected to recover, with a return to pre-COVID-19 sales by 2023.